BioCryst Pharmaceuticals
BCRX
BCRX
154 hedge funds and large institutions have $427M invested in BioCryst Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 43 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 35
33% less capital invested
Capital invested by funds: $635M → $427M (-$208M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
154
Holding in Top 10
2
Calls
$4.4M
Puts
$4.64M
Top Buyers
| 1 | +$13M | |
| 2 | +$4.39M | |
| 3 | +$4.39M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$3.12M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.08M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$4.26M | |
| 3 | -$3.98M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$3.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.2M |